Rab1A promotes cancer metastasis and radioresistance through activating GSK-3β/Wnt/β-catenin signaling in nasopharyngeal carcinoma

Many articles have reported that Rab1A was overexpressed in a variety of human cancers and involved in tumor progression and metastasis. However, the biological function and molecular mechanism of Rab1A in nasopharyngeal carcinoma (NPC) remained unknown until now. Here we found that Rab1A overexpression is a common event and was positively associated with distant metastasis and poor prognosis of NPC patients. Functionally, Rab1A depletion inhibited the migration and EMT phenotype of NPC cells, whereas Rab1A overexpression led to the opposite effect. Furthermore, we reveal an important role for Rab1A protein in the induction of radioresistance via regulating homologous recombination (HR) signaling pathway. Mechanistically, Rab1A activated Wnt/β-catenin signaling by inhibiting the activity of GSK-3β via phosphorylation at Ser9. Then Wnt/β-catenin signaling induced NPC cells radioresistance and metastasis through nuclear translocation of β-catenin and transcription upregulation of HR pathway-related and EMT-related genes expression. In general, this study shows that Rab1A may serve as a potential biomarker for predicting prognosis in NPC patients. Targeting Rab1A and Wnt/β-catenin signaling may hold promise to overcome NPC radioresistance.

[1]  Y. Bu,et al.  The Homologous Recombination Repair Pathway is Associated with Resistance to Radiotherapy in Nasopharyngeal Carcinoma , 2020, International journal of biological sciences.

[2]  J. Mao,et al.  Prognosis Significance and Positive Correlation of Rab1A and p-S6K/Gli1 Expression in Gastric Cancer. , 2019, Anti-cancer agents in medicinal chemistry.

[3]  Hong Zhang,et al.  LINC01133 as ceRNA inhibits gastric cancer progression by sponging miR-106a-3p to regulate APC expression and the Wnt/β-catenin pathway , 2018, Molecular Cancer.

[4]  Long-Bang Chen,et al.  The Role of Canonical Wnt Signaling in Regulating Radioresistance , 2018, Cellular Physiology and Biochemistry.

[5]  Z. Zeng,et al.  BPIFB1 (LPLUNC1) inhibits radioresistance in nasopharyngeal carcinoma by inhibiting VTN expression , 2018, Cell Death & Disease.

[6]  Hui-Yun Wang,et al.  BMP2 promotes proliferation and invasion of nasopharyngeal carcinoma cells via mTORC1 pathway , 2017, Aging.

[7]  Hongming Song,et al.  Inhibition of RAB1A suppresses epithelial-mesenchymal transition and proliferation of triple-negative breast cancer cells. , 2017, Oncology reports.

[8]  Xiao-Xing Li,et al.  Overexpression of Rab1B and MMP9 predicts poor survival and good response to chemotherapy in patients with colorectal cancer , 2017, Aging.

[9]  B. Jiang,et al.  Expression of Rab1A is upregulated in human lung cancer and associated with tumor size and T stage , 2016, Aging.

[10]  Wei Sun,et al.  Twist1 promotes radioresistance in nasopharyngeal carcinoma , 2016, Oncotarget.

[11]  Jianji Pan,et al.  Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial , 2016, The Lancet.

[12]  A. Bode,et al.  EBV-LMP1 suppresses the DNA damage response through DNA-PK/AMPK signaling to promote radioresistance in nasopharyngeal carcinoma. , 2016, Cancer letters.

[13]  Ying Sun,et al.  YPEL3 suppresses epithelial–mesenchymal transition and metastasis of nasopharyngeal carcinoma cells through the Wnt/β-catenin signaling pathway , 2016, Journal of Experimental & Clinical Cancer Research.

[14]  Xiao-Xing Li,et al.  Rab1 in Cell Signaling, Cancer and Other Diseases , 2016, Oncogene.

[15]  Stephen T. C. Wong,et al.  EMT is not required for lung metastasis but contributes to chemoresistance , 2015, Nature.

[16]  Anne W M Lee,et al.  Management of Nasopharyngeal Carcinoma: Current Practice and Future Perspective. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  Xiao-Xing Li,et al.  Aberrant amino acid signaling promotes growth and metastasis of hepatocellular carcinomas through Rab1A-dependent activation of mTORC1 by Rab1A , 2015, Oncotarget.

[18]  T. Lawrence,et al.  Molecular Pathways: Overcoming Radiation Resistance by Targeting DNA Damage Response Pathways , 2015, Clinical Cancer Research.

[19]  P. Widłak,et al.  Ionizing radiation affects protein composition of exosomes secreted in vitro from head and neck squamous cell carcinoma. , 2015, Acta biochimica Polonica.

[20]  A. Jemal,et al.  Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.

[21]  W. Woodward,et al.  ATM-mediated stabilization of ZEB1 promotes DNA damage response and radioresistance through CHK1 , 2014, Nature Cell Biology.

[22]  P. Kantoff,et al.  MiR-221 promotes the development of androgen independence in prostate cancer cells via downregulation of HECTD2 and RAB1A , 2014, Oncogene.

[23]  Ying Liang,et al.  Leukemia inhibitory factor promotes nasopharyngeal carcinoma progression and radioresistance. , 2013, The Journal of clinical investigation.

[24]  Demosthenes Bouros,et al.  H2AX a Promising Biomarker for Lung Cancer: A Review , 2013, Cancer investigation.

[25]  G. Zhu,et al.  MicroRNA-324-3p regulates nasopharyngeal carcinoma radioresistance by directly targeting WNT2B. , 2013, European journal of cancer.

[26]  Young Eun Choi,et al.  Charity begins at home: non-coding RNA functions in DNA repair , 2013, Nature Reviews Molecular Cell Biology.

[27]  Nicola J. Curtin,et al.  DNA repair dysregulation from cancer driver to therapeutic target , 2012, Nature Reviews Cancer.

[28]  Hans Clevers,et al.  Wnt/β-Catenin Signaling and Disease , 2012, Cell.

[29]  P. Olive,et al.  Retention of γH2AX foci as an indication of lethal DNA damage. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[30]  Q. Pan,et al.  MicroRNA-10b induced by Epstein-Barr virus-encoded latent membrane protein-1 promotes the metastasis of human nasopharyngeal carcinoma cells. , 2010, Cancer letters.

[31]  S. Teo,et al.  The ATM tumour suppressor gene is down‐regulated in EBV‐associated nasopharyngeal carcinoma , 2009, The Journal of pathology.

[32]  M. Newton,et al.  Genome-wide expression profiling reveals EBV-associated inhibition of MHC class I expression in nasopharyngeal carcinoma. , 2006, Cancer research.

[33]  Xi He,et al.  A dual-kinase mechanism for Wnt co-receptor phosphorylation and activation , 2005, Nature.

[34]  L Cawkwell,et al.  Radioresistance in carcinoma of the breast. , 2004, Breast.

[35]  M. Port,et al.  Comparison of the abundance of 10 radiation‐induced proteins with their differential gene expression in L929 cells , 2003, International journal of radiation biology.

[36]  M. Frankenberg-Schwager,et al.  Effect of dose rate on the induction of DNA double-strand breaks in eucaryotic cells. , 1981, Radiation research.

[37]  Pelayo Vilar,et al.  Nasopharyngeal Carcinoma , 1966 .

[38]  Hui-Yun Wang,et al.  Rab1A Is an mTORC1 Activator and a Colorectal Oncogene. , 2016, Cancer cell.

[39]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[40]  T. Giordano,et al.  GSK3beta and beta-catenin modulate radiation cytotoxicity in pancreatic cancer. , 2010, Neoplasia.